首页 | 本学科首页   官方微博 | 高级检索  
     

UPLC同时测定生脉饮口服液中五味子醇甲、五味子醇乙、五味子甲素的含量
引用本文:支旭然, 张黎媛, 赵娜, 董占军. UPLC同时测定生脉饮口服液中五味子醇甲、五味子醇乙、五味子甲素的含量[J]. 中国现代应用药学, 2021, 38(4): 426-429. DOI: 10.13748/j.cnki.issn1007-7693.2021.04.008
作者姓名:支旭然  张黎媛  赵娜  董占军
作者单位:1.河北省人民医院, 石家庄 050051
基金项目:河北省医学科学研究重点课题计划项目(20170325)
摘    要:
目的 建立UPLC测定生脉饮口服液中有效成分(五味子醇甲、五味子醇乙、五味子甲素)含量的方法。方法 采用XBridge® BEH C18色谱柱(2.1 mm×100 mm,2.5 μm),以乙腈(A)-水(B)为流动相进行梯度洗脱,流速0.5 mL·min-1,进样量5 μL;柱温为40℃;检测波长为203 nm。结果 五味子醇甲、五味子醇乙、五味子甲素检测质量浓度线性范围分别为1.950~124.8μg·mL-1r=0.999 9)、1.375~88.00μg·mL-1r=0.999 9)、1.594~102.0μg·mL-1r=0.999 9);定量限≤0.137 5μg·mL-1,检测限≤0.068 8μg·mL-1;仪器精密度、稳定性、重复性试验的RSD≤1.18%;加样回收率分别为98.65%(RSD=0.82%),98.47%(RSD=1.21%),99.24%(RSD=0.99%)。结论 该方法操作简便,仪器精密度、稳定性、重复性好,可用于生脉饮口服液中五味子醇甲、五味子醇乙、五味子甲素含量测定。

关 键 词:超高效液相色谱法  生脉饮口服液  五味子醇甲  五味子醇乙  五味子甲素
收稿时间:2020-01-10

Simultaneous Determination of Schisandrin A,Schisandrin B and Deoxyschizandrin in Shengmaiyin Oral Liquid by UPLC
ZHI Xuran, ZHANG Liyuan, ZHAO Na, DONG Zhanjun. Simultaneous Determination of Schisandrin A, Schisandrin B and Deoxyschizandrin in Shengmaiyin Oral Liquid by UPLC[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(4): 426-429. DOI: 10.13748/j.cnki.issn1007-7693.2021.04.008
Authors:ZHI Xuran  ZHANG Liyuan  ZHAO Na  DONG Zhanjun
Affiliation:1.Hebei General Hospital, Shijiazhuang 050051, China
Abstract:
OBJECTIVE To establish quantitative analysis method of effecctive components(schisandrin A, schisandrin B and deoxyschizandrin) in Shengmaiyin oral liquid by UPLC. METHODS The samples were separated on a XBridge® BEH C18 (2.1 mm×100 mm, 2.5 μm). The mobile phase was composed of acetonitrile(A) and water(B) with gradient elution, the flow rate was 0.5 mL·min-1 and the injection volume was 5 μL. The column temperature was 40℃ and detection wavelength was 203 nm. RESULTS The linear ranges were 1.950-124.8 µg·mL-1 for schisandrin A(r=0.999 9), 1.375-88.00 µg·mL-1 for schisandrin B(r=0.999 9), 1.594-102.0 µg·mL-1 for deoxyschizandrin(r=0.999 9). The limits of quantify were no more than 0.137 5 µg·mL-1, limits of detection were no more than 0.068 8 µg·mL-1; RSDs of instrument precision, stability and reproducibility tests were ≤ 1.18%; the recoveries were 98.65%(RSD=0.82%), 98.47%(RSD=1.21%), 99.24%(RSD=0.99%), respectively. CONCLUSION The method is simple, precise, stable and reproducible, and can be used for simultaneous determination of schisandrin A, schisandrin B and deoxyschizandrin in Shengmaiyin oral liquid.
Keywords:UPLC  Shengmaiyin oral liquid  schisandrin A  schisandrin B  deoxyschizandrin
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号